Show results for
Refine by
Clinical Trials Services In Israel
6 services found
Manufactured by:Biobeat Medical Smart-Monitoring based inTel Aviv, ISRAEL
Biobeat’s solution for clinical trials and research enhances clinical data access using our remote monitoring devices alongside our AI tools that are based on experience with more than 10,000 patients and subjects monitored to date, and millions of generated vital sign data sets. ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology’s clinical flow cytometry services are implemented using fully optimized and validated human panels developed to be customizable to meet your clinical trial needs. Champions Oncology leads the industry in clinical flow cytometry expertise and innovative technology that provides you with the highest ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology has a team of highly qualified PhD flow cytometrists with the expertise in oncology modeling as well as phenotypic analysis to ensure your data is reliable and scientifically relevant to your clinical trial. We work with you to define reportables for each flow cytometry panel that was developed and validated and ensure the data is reported in ...
Manufactured by:BioT Medical based inPetach Tikva, ISRAEL
Furthermore, as a device company you'd probably like to know if your device is as effective in the real world as it was during the clinical trial. BioT provides you with the set of tools to both comply and analyze your device efficacy. ...
by:Science in Action based inNess Ziona, ISRAEL
SCOPUS is a Clinical Arm of “Science in Action” research organization that offers a broad range of clinical development services in all stages and aspects of study design. Our scientific background and “hands on” experience to design, develop and execute early as well as advanced clinical development programs allow you to ...
by:elminda Ltd. based inHerzliya, ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in understanding drug mechanism, identifying ...